Ana C. Estrada

Ana C. Estrada

Auto-generated profile, based on publicly available information

Ana C. Estrada

Department of Biomedical Engineering, Yale University, New Haven, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2020 in Biomechanics and Modeling in Mechanobiology
Verified
Journal Article
Closed access
PDF file
AEAna C. Estrada
Ana C. Estrada
KYKyoko Yoshida
Kyoko Yoshida
JSJeffrey J. Saucerman
Jeffrey J. Saucerman
JHJeffrey W. Holmes
Jeffrey W. Holmes

4 March 2019 in npj Regenerative Medicine
Verified
Journal Article
Open access
PDF file
ESEkaterina Salimova
Ekaterina Salimova
KNKristen J. Nowak
Kristen J. Nowak
AEAna C. Estrada
Ana C. Estrada
MFMilena B. Furtado
Milena B. Furtado
EMElyshia McNamara
Elyshia McNamara
NRNadia A. Rosenthal
Nadia A. Rosenthal
Clinical variation in patient responses to myocardial infarction (MI) has been difficult to model in laboratory animals. To assess the genetic basis of variation in outcomes after heart attack, we characterized responses to acute MI in the Collaborative Cross (CC), a multi-parental panel of genetically diverse mouse strains. Striking differences in post-MI functional, morphological, and myocardial scar features were detected across 32 CC founder and recombinant inbred strains. Transcriptomic analyses revealed a plausible link between increased intrinsic cardiac oxidative phosphorylation levels and MI-induced heart failure. The emergence of significant quantitative trait loci for several post-MI traits indicates that utilizing CC strains is a valid approach for gene network discovery in cardiovascular disease, enabling more accurate clinical risk assessment and prediction.

13 December 2021 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
AEAna C. Estrada
Ana C. Estrada
LILinda Irons
Linda Irons
BRBruno V. Rego
Bruno V. Rego
GLGuangxin Li
Guangxin Li
GTGeorge Tellides
George Tellides
JHJay D. Humphrey
Jay D. Humphrey
Thoracic aortopathy–aneurysm, dissection, and rupture–is increasingly responsible for significant morbidity and mortality. Advances in medical genetics and imaging have improved diagnosis and thus enabled earlier prophylactic surgical intervention in many cases. There remains a pressing need, however, to understand better the underlying molecular and cellular mechanisms with the hope of finding robust pharmacotherapies. Diverse studies in patients and mouse models of aortopathy have revealed critical changes in multiple smooth muscle cell signaling pathways that associate with disease, yet integrating information across studies and models has remained challenging. We present a new quantitative network model that includes many of the key smooth muscle cell signaling pathways and validate the model using a detailed data set that focuses on hyperactivation of the mechanistic target of rapamycin (mTOR) pathway and its inhibition using rapamycin. We show that the model can be parameterized to capture the primary experimental findings both qualitatively and quantitatively. We further show that simulating a population of cells by varying receptor reaction weights leads to distinct proteomic clusters within the population, and that these clusters emerge due to a bistable switch driven by positive feedback in the PI3K/AKT/mTOR signaling pathway.

22 July 2022 in Biomechanics and Modeling in Mechanobiology
Verified
Journal Article
Closed access
PDF file
LILinda Irons
Linda Irons
AEAna C. Estrada
Ana C. Estrada
JHJay D. Humphrey
Jay D. Humphrey

4 February 2025 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
AEAna C. Estrada
Ana C. Estrada
JHJay D. Humphrey
Jay D. Humphrey

15 May 2024 in Journal of Biomechanics
Verified
Journal Article
Closed access
AEAna C. Estrada
Ana C. Estrada
LILinda Irons
Linda Irons
GTGeorge Tellides
George Tellides
JHJay D. Humphrey
Jay D. Humphrey